Linda Huynh
Internal Medicine · San Diego, CANPI 1407295033
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $670 and has fallen 97.3% since, to $18 in 2023.
Across 62 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$144
- Vanda Pharmaceuticals Inc.$120
- Lilly USA, LLC$106
- Amarin Pharma, Inc.$90
- Biohaven Pharmaceuticals, Inc.$67
- Abbott$63
- plus $563 from 22 others
What the payments were for
- Food & beverage$1,152100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $144 |
| Vanda Pharmaceuticals Inc. | 5 | $120 |
| Lilly USA, LLC | 7 | $106 |
| Amarin Pharma, Inc. | 4 | $90 |
| Biohaven Pharmaceuticals, Inc. | 3 | $67 |
| Abbott | 3 | $63 |
| Antares Pharma, Inc. | 3 | $62 |
| Novo Nordisk | 2 | $44 |
| Shire North American Group Inc | 2 | $43 |
| Boehringer Ingelheim | 2 | $42 |
| AstraZeneca | 3 | $39 |
| Stryker | 1 | $38 |
| Medtronic | 2 | $31 |
| Pfizer | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Tactile Systems Technology Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Seqirus USA Inc | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Boston Scientific | 1 | $12 |
| Galderma Laboratories, L.p. | 1 | $11 |
How this compares
$1,152 in reported general payments places this provider in the 75th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Diego
- Hatim HusainSan Diego$2M
- Steven EdelmanSan Diego$863K
- Christian RamersSan Diego$675K
- Adam ZweigSan Diego$421K
- James BreitmeyerSan Diego$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Teck LingPalo Alto$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.